Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of Snail.
Veena MS, Gahng JJ, Alani M, Ko AY, Basak SK, Liu IY, Hwang KJ, Chatoff JR, Venkatesan N, Morselli M, Yan W, Ali I, Kaczor-Urbanowicz KE, Gowda BS, Frost P, Pellegrini M, Moatamed NA, Wilczynski SP, Bomont P, Wang MB, Shin DS, Srivatsan ES. Veena MS, et al. Among authors: srivatsan es. Cancer Res Commun. 2024 Mar 8;4(3):706-722. doi: 10.1158/2767-9764.CRC-23-0331. Cancer Res Commun. 2024. PMID: 38421310 Free PMC article.
EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy.
Kang JJ, Ko A, Kil SH, Mallen-St Clair J, Shin DS, Wang MB, Srivatsan ES. Kang JJ, et al. Among authors: srivatsan es. Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188827. doi: 10.1016/j.bbcan.2022.188827. Epub 2022 Oct 27. Biochim Biophys Acta Rev Cancer. 2023. PMID: 36309124 Review.
Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.
Veena MS, Raychaudhuri S, Basak SK, Venkatesan N, Kumar P, Biswas R, Chakrabarti R, Lu J, Su T, Gallagher-Jones M, Morselli M, Fu H, Pellegrini M, Goldstein T, Aladjem MI, Rettig MB, Wilczynski SP, Shin DS, Srivatsan ES. Veena MS, et al. Among authors: srivatsan es. J Biol Chem. 2020 Dec 11;295(50):17169-17186. doi: 10.1074/jbc.RA120.014048. Epub 2020 Oct 7. J Biol Chem. 2020. PMID: 33028635 Free PMC article.
A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes.
Basak SK, Bera A, Yoon AJ, Morselli M, Jeong C, Tosevska A, Dong TS, Eklund M, Russ E, Nasser H, Lagishetty V, Guo R, Sajed D, Mudgal S, Mehta P, Avila L, Srivastava M, Faull K, Jacobs J, Pellegrini M, Shin DS, Srivatsan ES, Wang MB. Basak SK, et al. Among authors: srivatsan es. Cancer. 2020 Apr 15;126(8):1668-1682. doi: 10.1002/cncr.32644. Epub 2020 Feb 5. Cancer. 2020. PMID: 32022261 Free article. Clinical Trial.
Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.
Mohamed AA, Tan SH, Xavier CP, Katta S, Huang W, Ravindranath L, Jamal M, Li H, Srivastava M, Srivatsan ES, Sreenath TL, McLeod DG, Srinivasan A, Petrovics G, Dobi A, Srivastava S. Mohamed AA, et al. Among authors: srivatsan es. Mol Cancer Res. 2017 Oct;15(10):1308-1317. doi: 10.1158/1541-7786.MCR-17-0058. Epub 2017 Jun 12. Mol Cancer Res. 2017. PMID: 28607007 Free PMC article.
66 results